Ethinylestradiol/desogestrel - Organon

Drug Profile

Ethinylestradiol/desogestrel - Organon

Alternative Names: Mircette

Latest Information Update: 18 Nov 2009

Price : $50

At a glance

  • Originator Savient Pharmaceuticals
  • Class Alkylated estrogenic steroids; Hormonal contraceptives; Norpregnatrienes; Norpregnenes; Oral contraceptives
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Contraception

Most Recent Events

  • 19 Nov 2007 Organon has been acquired and merged into Schering-Plough
  • 31 Jan 2003 A study has been added to the Women's Health therapeutic trials section
  • 24 Jul 1998 Launched for Contraception/Pregnancy (Prevention) in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top